Beck Mack & Oliver’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-13,176
Closed -$1.15M 300
2015
Q4
$1.15M Sell
13,176
-2,862
-18% -$245K 0.04% 138
2015
Q3
$1.3M Sell
16,038
-2,830
-15% -$246K 0.04% 146
2015
Q2
$1.68M Sell
18,868
-2,025
-10% -$177K 0.04% 132
2015
Q1
$1.81M Sell
20,893
-690
-3% -$57.9K 0.05% 131
2014
Q4
$1.83M Buy
21,583
+15
+0.1% +$1.17K 0.04% 129
2014
Q3
$1.52M Buy
21,568
+70
+0.3% +$4.99K 0.04% 147
2014
Q2
$1.49M Sell
21,498
-31
-0.1% -$2.18K 0.03% 145
2014
Q1
$1.62M Sell
21,529
-200
-0.9% -$15K 0.04% 139
2013
Q4
$1.53M Buy
21,729
+14,172
+188% +$925K 0.04% 148
2013
Q3
$467K Buy
7,557
+362
+5% +$23.4K 0.01% 238
2013
Q2
$444K Buy
+7,195
New +$433K 0.01% 240

Other funds holding ESRX

Beck Mack & Oliver's ESRX Position: Q1 2016 in Review

Beck Mack & Oliver sold out of Express Scripts Holding Company (ESRX) in Q1 2016, closing a stake of 13,176 shares — an estimated $1.15M sold.

Beck Mack & Oliver first reported a position in ESRX in Q2 2013 and held it in 11 quarters. The position peaked at $1.83M in Q4 2014. 1,221 funds tracked by Wall St. Rank hold ESRX as of Q1 2016.

  • Beck Mack & Oliver reported no remaining Express Scripts Holding Company position as of Q1 2016 after selling out during the quarter.
  • Beck Mack & Oliver sold 13,176 Express Scripts Holding Company shares in Q1 2016, an estimated $1.15M.
  • Beck Mack & Oliver first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 11 quarters.
  • Beck Mack & Oliver's Express Scripts Holding Company position peaked at $1.83M in Q4 2014.
  • 1,221 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q1 2016.

Based on Beck Mack & Oliver's 13F filing for Q1 2016, filed 27 Apr 2016.